In our current study, we found that FFLZ inhibits Akt and PI3K phosphorylation, indicating that FFLZ directly down-regulates the TGFR non-Smad pathway and consequently inhibits survival signaling in breast cancer cells. The gene discussed is AKT1; the disease is breast cancer.